By sparking the immune system into action, radiation therapy makes certain tumors that resist immunotherapy susceptible to ...

During a live event, Bruna Pellini, MD, discussed IO monotherapy as a first-line option for non–small cell lung cancer with ...

Scientists have uncovered a molecular "on–off" switch that helps lung adenocarcinoma—the most common form of lung cancer—grow ...

Brahmer: Immunotherapy is approved for the first-line treatment of patients with metastatic lung cancer who have high levels of PDL-1. PDL-1 is a protein some lung cancers release to prevent the ...

From cell-manufacturing laboratories to outpatient infusion facilities, health systems are rapidly adapting to a new kind of cancer treatment that demands individualized care, infrastructure and ...

Researchers pinpoint what happens on a cellular and molecular level over time when the cancer is treated with either ...

Lung cancer outcomes significantly improved with immunotherapy-based treatment given before and after surgery Date: October 23, 2023 Source: University of Texas M. D. Anderson Cancer Center ...

Corticosteroids, a commonly prescribed medication to alleviate cancer-related symptoms for non-small cell lung cancer patients treated with immunotherapy, are the main reason certain immunotherapies ...

Learn more about what the research says about immunotherapy for small cell lung cancer (SCLC), including efficacy, clinical trials, and combination with other treatments.

Combining immunotherapy with chemotherapy nearly doubled the survival time of non-small cell lung cancer patients compared to patients treated with chemotherapy alone, new research shows.

Lung cancer: AI shows who will benefit from immunotherapy By Maria Cohut, Ph.D. on November 25, 2019 — Fact checked by Paula Field Lung cancer is a common and often aggressive form of cancer.

Lung cancer may be curable, depending on a number of factors, including your age, health, stage of cancer, and how it ...